Ozempic pill results in 15% weight loss: Novo Nordisk

A pill version of Ozempic (semaglutide), a Type 2 diabetes drug in high demand for its off-label use for weight loss, resulted in 15.1 percent weight loss among phase 3 study participants. 

Read the full post at Becker's Hospital Review - Healthcare News